{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:27:38Z","timestamp":1791872858764,"version":"4.3.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,8,9]],"date-time":"2013-08-09T00:00:00Z","timestamp":1376006400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1007\/s11239-013-0978-9","type":"journal-article","created":{"date-parts":[[2013,8,8]],"date-time":"2013-08-08T13:00:45Z","timestamp":1375966845000},"page":"105-114","source":"Crossref","is-referenced-by-count":12,"title":["Nutri-pharmacogenomics of warfarin anticoagulation therapy: VKORC1 genotype-dependent influence of dietary vitamin K intake"],"prefix":"10.1007","volume":"38","author":[{"given":"Ryuhei","family":"Saito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayo","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Fujibayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Wakasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Motoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizuho","family":"Iwadare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoko","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nakaba","family":"Fujioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taketsugu","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironobu","family":"Akao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michihiko","family":"Kitayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouji","family":"Kajinami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,9]]},"reference":[{"key":"978_CR1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/bmj.329.7456.15","volume":"329","author":"M Pirmohamed","year":"2004","unstructured":"Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Park BK, Breckenridge AM (2004) Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 329:15\u201319","journal-title":"BMJ"},{"key":"978_CR2","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2125.2007.03064.x","volume":"65","author":"K Wester","year":"2008","unstructured":"Wester K, Jonsson AK, Spigset O, Druid H, H\u00e4gg S (2008) Incidence of fatal adverse drug reactions: a population based study. Br J Clin Pharmacol 65:573\u2013579","journal-title":"Br J Clin Pharmacol"},{"key":"978_CR3","doi-asserted-by":"crossref","first-page":"851","DOI":"10.2217\/14622416.8.7.851","volume":"8","author":"AH Wu","year":"2007","unstructured":"Wu AH (2007) Use of genetic and nongenetic factors in warfarin dosing algorithms. Pharmacogenomics 8:851\u2013861","journal-title":"Pharmacogenomics"},{"key":"978_CR4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1055\/s-2003-44461","volume":"3","author":"MA Crowther","year":"2003","unstructured":"Crowther MA (2003) Oral anticoagulant initiation: rationale for the use of warfarin dosing nomograms. Semin Vasc Med 3:255\u2013260","journal-title":"Semin Vasc Med"},{"key":"978_CR5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/sj.tpj.6500417","volume":"7","author":"M Wadelius","year":"2007","unstructured":"Wadelius M, Pirmohamed M (2007) Pharmacogenetics of warfarin: current status and future challenges. Pharmacogenomics J 7:99\u2013111","journal-title":"Pharmacogenomics J"},{"key":"978_CR6","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1161\/CIR.0b013e31825b07f8","volume":"126","author":"EA Ashley","year":"2012","unstructured":"Ashley EA, Hershberger RE, Caleshu C, Ellinor PT, Garcia JG, Herrington DM, Ho CY, Johnson JA, Kittner SJ, Macrae CA, Mudd-Martin G, Rader DJ, Roden DM, Scholes D, Sellke FW et al (2012) Genetics and cardiovascular disease: a policy statement from the American Heart Association. Circulation 126:142\u2013157","journal-title":"Circulation"},{"key":"978_CR7","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1161\/CIRCULATIONAHA.111.070920","volume":"125","author":"JL Anderson","year":"2012","unstructured":"Anderson JL, Horne BD, Stevens SM, Woller SC, Samuelson KM, Mansfield JW, Robinson M, Barton S, Brunisholz K, Mower CP, Huntinghouse JA, Rollo JS, Siler D, Bair TL, Knight S, Muhlestein JB, Carlquist JF (2012) A randomized and clinical effectiveness trial comparing two pharmacogenetic algorithms and standard care for individualizing warfarin dosing (CoumaGen-II). Circulation 125:1997\u20132005","journal-title":"Circulation"},{"key":"978_CR8","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1160\/TH04-06-0346","volume":"92","author":"D Kurnik","year":"2004","unstructured":"Kurnik D, Loebstein R, Rabinovitz H, Austerweil N, Halkin H, Almog S (2004) Over-the-counter vitamin K1-containing multivitamin supplements disrupt warfarin anticoagulation in vitamin K1-depleted patients: a prospective, controlled trial. Thromb Haemost 92:1018\u20131024","journal-title":"Thromb Haemost"},{"key":"978_CR9","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.amjmed.2003.12.036","volume":"116","author":"V Franco","year":"2004","unstructured":"Franco V, Polanczyk CA, Clausell N, Rohde LE (2004) Role of dietary vitamin K intake in chronic oral anticoagulation: prospective evidence from observational and randomized protocols. Am J Med 116:651\u2013656","journal-title":"Am J Med"},{"key":"978_CR10","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1182\/blood.V104.11.1682.1682","volume":"104","author":"LJ Schurgers","year":"2004","unstructured":"Schurgers LJ, Shearer MJ, Hamuly\u00e1k K, St\u00f6cklin E, Vermeer C (2004) Effect of vitamin K intake on the stability of oral anticoagulant treatment: dose response relationships in healthy subjects. Blood 104:1682\u20131689","journal-title":"Blood"},{"key":"978_CR11","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1161\/CIRCULATIONAHA.109.849208","volume":"120","author":"MC Assis de","year":"2009","unstructured":"de Assis MC, Rabelo ER, \u00c1vila CW, Polanczyk CA, Rohde LE (2009) Improved oral anticoagulation after a dietary vitamin K-guided strategy: a randomized controlled trial. Circulation 120:1115\u20131122","journal-title":"Circulation"},{"key":"978_CR12","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1373\/clinchem.2008.115295","volume":"55","author":"T Aomori","year":"2009","unstructured":"Aomori T, Yamamoto K, Oguchi-Katayama A, Kawai Y, Ishidao T, Mitani Y, Kogo Y, Lezhava A, Fujita Y, Obayashi K, Nakamura K, Kohnke H, Wadelius M, Ekstr\u00f6m L, Skogastierna C et al (2009) Rapid single-nucleotide polymorphism detection of cytochrome P450 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genes for the warfarin dose adjustment by the SMart-amplification process version 2. Clin Chem 55:804\u2013812","journal-title":"Clin Chem"},{"key":"978_CR13","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.clpt.2006.04.010","volume":"80","author":"K Obayashi","year":"2006","unstructured":"Obayashi K, Nakamura K, Kawana J, Ogata H, Hanada K, Kurabayashi M, Hasegawa A, Yamamoto K, Horiuchi R (2006) VKORC1 gene variations are the major contributors of variation in warfarin dose in Japanese patients. Clin Pharmacol Ther 80:169\u2013178","journal-title":"Clin Pharmacol Ther"},{"key":"978_CR14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10038-005-0354-5","volume":"51","author":"T Mushiroda","year":"2006","unstructured":"Mushiroda T, Ohnishi Y, Saito S, Takahashi A, Kikuchi Y, Saito S, Shimomura H, Wanibuchi Y, Suzuki T, Kamatani N, Nakamura Y (2006) Association of VKORC1 and CYP2C9 polymorphisms with warfarin dose requirements in Japanese patients. J Hum Genet 51:249\u2013253","journal-title":"J Hum Genet"},{"key":"978_CR15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.thromres.2006.09.007","volume":"120","author":"R Kimura","year":"2007","unstructured":"Kimura R, Miyashita K, Kokubo Y, Akaiwa Y, Otsubo R, Nagatsuka K, Otsuki T, Okayama A, Minematsu K, Naritomi H, Honda S, Tomoike H, Miyata T (2007) Genotypes of vitamin K epoxide reductase, gamma-glutamyl carboxylase, and cytochrome P450 2C9 as determinants of daily warfarin dose in Japanese patients. Thromb Res 120:181\u2013186","journal-title":"Thromb Res"},{"key":"978_CR16","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.thromres.2008.11.011","volume":"124","author":"M Yoshizawa","year":"2009","unstructured":"Yoshizawa M, Hayashi H, Tashiro Y, Sakawa S, Moriwaki H, Akimoto T, Doi O, Kimura M, Kawarasaki Y, Inoue K, Itoh K (2009) Effect of VKORC1-1639 G\u00a0>\u00a0A polymorphism, body weight, age, and serum albumin alterations on warfarin response in Japanese patients. Thromb Res 124:161\u2013166","journal-title":"Thromb Res"},{"key":"978_CR17","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature02214","volume":"427","author":"S Rost","year":"2004","unstructured":"Rost S, Fregin A, Ivaskevicius V, Conzelmann E, H\u00f6rtnagel K, Pelz HJ, Lappegard K, Seifried E, Scharrer I, Tuddenham EG, M\u00fcller CR, Strom TM, Oldenburg J (2004) Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2. Nature 427:537\u2013541","journal-title":"Nature"},{"key":"978_CR18","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nature02254","volume":"427","author":"T Li","year":"2004","unstructured":"Li T, Chang CY, Jin DY, Lin PJ, Khvorova A, Stafford DW (2004) Identification of the gene for vitamin K epoxide reductase. Nature 427:541\u2013544","journal-title":"Nature"},{"key":"978_CR19","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJMoa0809329","volume":"360","author":"The International Warfarin Pharmacogenetics Consortium","year":"2009","unstructured":"The International Warfarin Pharmacogenetics Consortium (2009) Estimation of the Warfarin dose with clinical and pharmacogenetic data. N Engl J Med 360:753\u2013764","journal-title":"N Engl J Med"},{"key":"978_CR20","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1016\/j.jacc.2010.03.009","volume":"55","author":"RS Epstein","year":"2010","unstructured":"Epstein RS, Moyer TP, Aubert RE, O\u2019Kane DJ, Xia F, Verbrugge RR, Gage BF, Teagarden JR (2010) Warfarin genotyping reduces hospitalization rates. Results from the MM-WES (Medco\u2013Mayo Warfarin Effectiveness Study). J Am Coll Cardiol 55:2804\u20132812","journal-title":"J Am Coll Cardiol"},{"key":"978_CR21","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1056\/NEJMoa044503","volume":"352","author":"MJ Rieder","year":"2005","unstructured":"Rieder MJ, Reiner AP, Gage BF, Nickerson DA, Eby CS, McLeod HL, Blough DK, Thummel KE, Veenstra DL, Rettie AE (2005) Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose. N Engl J Med 352:2285\u20132293","journal-title":"N Engl J Med"},{"key":"978_CR22","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1093\/hmg\/ddi180","volume":"14","author":"HY Yuan","year":"2005","unstructured":"Yuan HY, Chen JJ, Lee MT, Wung JC, Chen YF, Charng MJ, Lu MJ, Hung CR, Wei CY, Chen CH, Wu JY, Chen YT (2005) A novel functional VKORC1 promoter polymorphism is associated with inter-individual and interethnic differences in warfarin sensitivity. Hum Mol Genet 14:1745\u20131751","journal-title":"Hum Mol Genet"},{"key":"978_CR23","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/j.1538-7836.2008.03003.x","volume":"6","author":"EA Sconce","year":"2008","unstructured":"Sconce EA, Avery PJ, Wynne HA, Kamali F (2008) Vitamin K epoxide reductase complex subunit 1 (VKORC1) polymorphism influences the anticoagulation response subsequent to vitamin K intake: a pilot study. J Thromb Haemost 6:1226\u20131228","journal-title":"J Thromb Haemost"},{"key":"978_CR24","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1161\/CIRCGENETICS.109.891366","volume":"2","author":"D Corella","year":"2009","unstructured":"Corella D, Ordovas JM (2009) Nutrigenomics in cardiovascular medicine. Circ Cardiovasc Genet 2:637\u2013651","journal-title":"Circ Cardiovasc Genet"},{"key":"978_CR25","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1182\/blood-2006-09-049262","volume":"109","author":"E Sconce","year":"2007","unstructured":"Sconce E, Avery P, Wynne H, Kamali F (2007) Vitamin K supplementation can improve stability of anticoagulation for patients with unexplained variability in response to warfarin. Blood 109:2419\u20132423","journal-title":"Blood"},{"key":"978_CR26","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1365-2125.2010.03672.x","volume":"70","author":"Y Lurie","year":"2010","unstructured":"Lurie Y, Loebstein R, Kurnik D, Almog S, Halkin H (2010) Warfarin and vitamin K intake in the era of pharmacogenetics. Br J Clin Pharmacol 70:164\u2013170","journal-title":"Br J Clin Pharmacol"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-013-0978-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-013-0978-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-013-0978-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T16:57:53Z","timestamp":1596301073000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-013-0978-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,9]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["978"],"URL":"https:\/\/doi.org\/10.1007\/s11239-013-0978-9","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,9]]}}}